Salivary gland hyalinizing clear-cell carcinoma with cutaneous metastasis: A rare and deceptive tumor.


Journal

Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 13 04 2020
revised: 10 06 2020
accepted: 01 07 2020
pubmed: 9 7 2020
medline: 2 10 2021
entrez: 9 7 2020
Statut: ppublish

Résumé

Clear-cell carcinoma (CCC) is an uncommon malignant tumor of minor salivary glands. It characteristically has a low-grade morphology and a favorable outcome by most reports. An EWSR1-ATF1 fusion can be detected in the majority of cases. We present a rare case of CCC, which had an aggressive course with the development of cutaneous metastases. Practicing dermatopathologists should be aware of this tumor given its low-grade appearance and histopathologic resemblance to other primary cutaneous adnexal and metastatic neoplasms.

Identifiants

pubmed: 32640078
doi: 10.1111/cup.13799
doi:

Substances chimiques

EWSR1-ATF1 fusion protein, human 0
Oncogene Proteins, Fusion 0

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-89

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Weinreb I. Hyalinizing clear cell carcinoma of salivary gland: a review and update. Head Neck Pathol. 2013;7(Suppl 1):S20-S29.
Sharbel DD, Unsal AA, Groves MW, Albergotti WG, Byrd JK. Salivary clear cell carcinoma clinicopathologic characteristics and outcomes: a population-based analysis. Ann Otol Rhinol Laryngol. 2019;128(11):989-996.
Daniele L, Nikolarakos D, Keenan J, Schaefer N, Lam AK. Clear cell carcinoma, not otherwise specified/hyalinising clear cell carcinoma of the salivary gland: the current nomenclature, clinical/pathological characteristics and management. Crit Rev Oncol Hematol. 2016;102:55-64.
Shah AA, LeGallo RD, van Zante A, et al. EWSR1 genetic rearrangements in salivary gland tumors: a specific and very common feature of hyalinizing clear cell carcinoma. Am J Surg Pathol. 2013;37(4):571-578.
Nakano T, Yamamoto H, Nishijima T, et al. Hyalinizing clear cell carcinoma with EWSR1-ATF1 fusion gene: report of three cases with molecular analyses. Virchows Arch. 2015;466(1):37-43.
Antonescu CR, Katabi N, Zhang L, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50(7):559-570.
Ni H, Wang XT, Xia QY, et al. Hyalinizing clear cell carcinoma of salivary gland: a clinicopathologic study. Zhonghua Bing Li Xue Za Zhi. 2016;45(8):577-578.
Skálová A, Weinreb I, Hyrcza M, et al. Clear cell myoepithelial carcinoma of salivary glands showing EWSR1 rearrangement: molecular analysis of 94 salivary gland carcinomas with prominent clear cell component. Am J Surg Pathol. 2015;39(3):338-348.
Chapman E, Skalova A, Ptakova N, et al. Molecular profiling of hyalinizing clear cell carcinomas revealed a subset of tumors harboring a novel EWSR1-CREM fusion: report of 3 cases. Am J Surg Pathol. 2018;42(9):1182-1189.
Ivan D, Nash JW, Prieto VG, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol. 2007;34(6):474-480.
Plaza JA, Ortega PF, Stockman DL, Suster S. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. J Cutan Pathol. 2010;37(4):403-410.
Kyrpychova L, Kacerovska D, Vanecek T, et al. Cutaneous hidradenoma: a study of 21 neoplasms revealing neither correlation between the cellular composition and CRTC1-MAML2 fusions nor presence of CRTC3-MAML2 fusions. Ann Diagn Pathol. 2016;23:8-13.
Nandeesh BN, Rajalakshmi T. A study of histopathologic spectrum of nodular hidradenoma. Am J Dermatopathol. 2012;34(5):461-470.
Alhatem A, Nudelman M, Schwartz RA, Hassoun P, Malliah RB, Lambert WC. Primary cutaneous clear cell sarcoma, clinical outcome with sentinel lymph nodes status. Am J Clin Pathol. 2020;153(6):799-810.
Luzar B, Billings SD, de la Fouchardiere A, Pissaloux D, Alberti L, Calonje E. Compound clear cell sarcoma of the skin-a potential diagnostic pitfall: report of a series of 4 new cases and a review of the literature. Am J Surg Pathol. 2020;44(1):21-29.
Hantschke M, Mentzel T, Rütten A, et al. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol. 2010;34(2):216-222.
Velez MJ, Thomas CL, Stratton J, Bergfeld W, Weaver J. The utility of using immunohistochemistry in the differentiation of metastatic, cutaneous clear cell renal cell carcinoma and clear cell hidradenoma. J Cutan Pathol. 2017;44(7):612-615.
Stuart LN, Tipton RG, DeWall MR, et al. Primary cutaneous perivascular epithelioid cell tumor (PEComa): five new cases and review of the literature. J Cutan Pathol. 2017;44(8):713-721.

Auteurs

Rand Abou Shaar (RA)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Sheeren Zia (S)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Mohamed Alhamar (M)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Theresa Romano (T)

Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.

Brandon Shaw (B)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Christian Keller (C)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.

Ben J Friedman (BJ)

Department of Pathology and Laboratory Medicine, Henry Ford Health System, Detroit, Michigan, USA.
Department of Dermatology, Henry Ford Health System, Detroit, Michigan, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH